Melhores Linfoma médicos em Israel - TOP-25 médicos

Especialista líder em linfoma no Sourasky Medical Center com mais de 30 anos de experiência especializada em oncologia.

• Professor Associado de Oncologia na Universidade de Tel-Aviv
• Membro do corpo docente da ESMO especializado em sarcoma e linfoma
• Extenso histórico de pesquisa com colaborações no Weizmann Institute
• Ex-chefe da Divisão de Oncologia no Sourasky
• Membro ativo na ASCO e IASLC para avanços na oncologia

O Dr. Ram Ron trabalha no renomado Sourasky Medical Center em Tel Aviv, trazendo especialização focada em casos complexos de linfoma.

• Mais de 25 anos de experiência clínica em oncologia
• Formação especializada (Fellowship) em oncologia para conhecimentos específicos
• Atuação em um grande departamento de oncologia multidisciplinar
• Diagnóstico e planeamento de tratamento avançado

O Dr. El Hasid realizou mais de 300 transplantes de medula óssea e sangue do cordão umbilical para crianças no Sourasky Medical Center.

• Chefiar o Departamento de Onco-hematologia e Oncologia Pediátrica do Hospital Infantil Dana Dwek
• Especializar-se em transplante pediátrico de medula óssea e sangue do cordão umbilical
• Publicar 50 artigos de pesquisa na área médica
• Membro da American Society of Hematology e da Israeli Society for Pediatric Hematooncology
• Adquirir experiência no City of Hope Hospital em Los Angeles

Ele realizou centenas de transplantes de células-tronco, um tratamento fundamental para o linfoma. O Dr. Ron Ram é um oncologista com tripla certificação no Sourasky Medical Center (Ichilov).

• Especializar-se especificamente em Hematologia e Oncologia Médica
• Concluir a sua especialização em oncologia no New York Medical College
• Contribuir para mais de 30 artigos científicos e um livro de medicina
• Ser experiente tanto em medicina interna quanto em cancros hematológicos avançados

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Chefe de Hematologia e Linfoma no Tel-Aviv Medical Center – O Prof. Joffe é especialista em casos complexos de linfoma, com formação avançada no Memorial Sloan Kettering.

• 35 anos de experiência em hemato-oncologia
• Especialização em linfoma difuso de grandes células B e linfoma do SNC
• Liderança de ensaios clínicos para novas imunoterapias de linfoma
• Médico sénior no Memorial Sloan Kettering Cancer Center
• Foco no tratamento personalizado baseado em perfil genético

O Prof. Shapira é especialista em transplante de medula óssea e lidera a equipe de tratamento no Sourasky Medical Center.

• Graduar-se na faculdade de medicina da Universidade Hebraica em 1999
• Especializar-se em medicina interna no Hadassah Medical Center
• Anteriormente médico sênior em um departamento de Transplante de Medula Óssea
• Falar inglês e hebraico para uma comunicação clara

Chefia o Instituto de Hemato-Oncologia do Sourasky Medical Center – um importante centro de tratamento de linfoma e leucemia desde 2003.

• 31 anos de prática como onco-hematologista
• Especializado no tratamento de linfomas, não apenas em oncologia geral
• Lidera o Departamento de Transplante de Medula Óssea

O Dr. Dror Levin chefia a hematologia oncológica pediátrica no Sourasky Medical Center, especializando-se em distúrbios sanguíneos e cancro ósseo em crianças.

• Pediatra sénior no Hospital Infantil 'Dana' com vasta experiência
• Coordenador do tratamento de cancro ósseo (sarcoma) em crianças
• Formado no Instituto Ortopédico Rizzoli em Bolonha – um líder mundial em ortopedia
• Membro da ISPHO (Sociedade Israelita de Hematologia e Oncologia Pediátrica)

O Dr. Yair é um hematologista de destaque, com vários prémios de excelência na investigação e tratamento de linfomas no Centro Médico Sourasky de Tel-Aviv.

• Especializar-se em casos de leucemia linfocítica crónica
• Vencedor de mais de 10 prémios prestigiados em hematologia
• Membro das associações de hematologia israelita e americana
• Formado nas principais instituições médicas israelitas

Reconhecido como um dos melhores médicos de Israel pela Forbes em 2019-2020, o Dr. Gal Goldstein é o Chefe de Oncologia Pediátrica do Hospital Hadassah.

• Especializar-se exclusivamente em hemato-oncologia pediátrica há mais de 20 anos
• Especialista em tratamentos avançados, como transplantes de medula óssea haploidentificos
• Foco profundo em cancros infantis específicos, incluindo o retinoblastoma
• Membro ativo de sociedades internacionais de oncologia, como a SIOP
• Empregar medicina de precisão para personalizar planos de tratamento

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Especializa-se exclusivamente em linfoma, concentrando a sua prática neste cancro do sangue complexo no Rambam Medical Center.

• Hematologista com profunda experiência em subtipos de linfoma
• Fornecer tratamentos direcionados para esta condição específica
• Sediado num prestigiado hospital de investigação e cuidados terciários

Karen Drumea é especialista em radioterapia oncológica, focando-se no tratamento de pacientes com câncer através de radiação no Rambam Medical Center.

• Anos de experiência em rádio-oncologia e oncologia geral
• Especialização no uso de radioterapia para tratar cânceres
• Sediada no Rambam Medical Center em Israel
• Combinação de experiência em oncologia radioterápica e médica para o atendimento ao paciente